Literature DB >> 20150613

Evaluation of [99mTc-(CO)3-X-Y-Bombesin(7-14)NH2] conjugates for targeting gastrin-releasing peptide receptors overexpressed on breast carcinoma.

Lauren B Retzloff1, Laura Heinzke, Said D Figureoa, Samantha V Sublett, Lixin Ma, Gary L Sieckman, Tammy L Rold, Isabel Santos, Timothy J Hoffman, Charles J Smith.   

Abstract

BACKGROUND: Gastrin-releasing peptide (GRP) receptors are overexpressed on a variety of human carcinomas, including those of the breast. These receptors may be targeted with bombesin (BBN), which binds to GRP receptors with high affinity and specificity. The aim of this study was to develop a (99m)Tc(I)-BBN analog with favorable pharmacokinetic properties in order to improve the visualization of breast cancer tissue.
MATERIALS AND METHODS: Solid-phase peptide synthesis was used to produce a series of X-Y-BBN-NH2 conjugates, where X is pyrazolyl (PZ1) or 2,3-diaminopropionic acid (DPR) and Y is a spacer sequence. Their metallated counterparts were prepared by reacting [(99m)Tc-(H(2)O)(3)(CO)(3)](+) with the corresponding ligand.
RESULTS: While the PZ1 conjugates exhibited higher GRP receptor binding affinities in vitro, the DPR analogs demonstrated superior target tissue accumulation and pharmacokinetic properties in vivo.
CONCLUSION: These results demonstrate the ability of the DPR derivatives (Y=glycylserylglycine, triserine) to clearly identify the T47-D tumor tissue in xenografted SCID mice.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20150613

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  10 in total

Review 1.  Bombesin receptor-mediated imaging and cytotoxicity: review and current status.

Authors:  Veronica Sancho; Alessia Di Florio; Terry W Moody; Robert T Jensen
Journal:  Curr Drug Deliv       Date:  2011-01       Impact factor: 2.565

2.  Development and Preclinical Evaluation of 99mTc- and 186Re-Labeled NOTA and NODAGA Bioconjugates Demonstrating Matched Pair Targeting of GRPR-Expressing Tumors.

Authors:  George Makris; Rajendra P Bandari; Marina Kuchuk; Silvia S Jurisson; Charles J Smith; Heather M Hennkens
Journal:  Mol Imaging Biol       Date:  2020-09-04       Impact factor: 3.488

3.  Synthesis and evaluation of novel gonadotropin-releasing hormone receptor-targeting peptides.

Authors:  Haixun Guo; Jie Lu; Helen Hathaway; Melanie E Royce; Eric R Prossnitz; Yubin Miao
Journal:  Bioconjug Chem       Date:  2011-07-20       Impact factor: 4.774

Review 4.  Bombesin related peptides/receptors and their promising therapeutic roles in cancer imaging, targeting and treatment.

Authors:  Paola Moreno; Irene Ramos-Álvarez; Terry W Moody; Robert T Jensen
Journal:  Expert Opin Ther Targets       Date:  2016-03-28       Impact factor: 6.902

5.  Inorganic chemistry in nuclear imaging and radiotherapy: current and future directions.

Authors:  Valerie Carroll; Dustin W Demoin; Timothy J Hoffman; Silvia S Jurisson
Journal:  Radiochim Acta       Date:  2012-08       Impact factor: 1.440

6.  Design and synthesis of a bombesin peptide-conjugated tripodal phosphino dithioether ligand topology for the stabilization of the fac-[M(CO)3]+ core (M=(99 m)Tc or Re).

Authors:  Raghuraman Kannan; Nagavarakishore Pillarsetty; Hariprasad Gali; Timothy J Hoffman; Charles L Barnes; Silvia S Jurisson; Charles J Smith; Wynn A Volkert
Journal:  Inorg Chem       Date:  2011-05-18       Impact factor: 5.165

7.  Monooxorhenium(V) complexes with 222-N2S2 MAMA ligands for bifunctional chelator agents: Syntheses and preliminary in vivo evaluation.

Authors:  Dustin Wayne Demoin; Ashley N Dame; William D Minard; Fabio Gallazzi; Gary L Seickman; Tammy L Rold; Nicole Bernskoetter; Michael E Fassbender; Timothy J Hoffman; Carol A Deakyne; Silvia S Jurisson
Journal:  Nucl Med Biol       Date:  2016-08-31       Impact factor: 2.408

8.  Radiolabeled peptides: valuable tools for the detection and treatment of cancer.

Authors:  M Fani; H R Maecke; S M Okarvi
Journal:  Theranostics       Date:  2012-05-16       Impact factor: 11.556

Review 9.  Radiolabelled peptides for oncological diagnosis.

Authors:  Peter Laverman; Jane K Sosabowski; Otto C Boerman; Wim J G Oyen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-02       Impact factor: 9.236

10.  99mTc-radiolabeled GE11-modified peptide for ovarian tumor targeting.

Authors:  Najmeh Rahmanian; Seyed Jalal Hosseinimehr; Ali Khalaj; Zohreh Noaparast; Seyed Mohammad Abedi; Omid Sabzevari
Journal:  Daru       Date:  2017-05-02       Impact factor: 3.117

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.